argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
560.24
-3.07 (-0.54%)
At close: Jul 11, 2025, 4:00 PM
556.69
-3.55 (-0.63%)
After-hours: Jul 11, 2025, 6:15 PM EDT
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,652,947
Profits / Employee
$665,482
Market Cap
34.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,599 | 451 | 39.29% |
Dec 31, 2023 | 1,148 | 305 | 36.18% |
Dec 31, 2022 | 843 | 193 | 29.69% |
Dec 31, 2021 | 650 | 314 | 93.45% |
Dec 31, 2020 | 336 | 148 | 78.72% |
Dec 31, 2019 | 188 | 83 | 79.05% |
Dec 31, 2018 | 105 | 32 | 43.84% |
Dec 31, 2017 | 73 | 15 | 25.86% |
Dec 31, 2016 | 58 | 17 | 41.46% |
Dec 31, 2015 | 41 | 9 | 28.13% |
Dec 31, 2014 | 32 | 10 | 45.45% |
Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ARGX News
- 12 days ago - FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls - Benzinga
- 22 days ago - argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire
- 4 weeks ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - GlobeNewsWire
- 5 weeks ago - argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - argenx Announces Results of Annual General Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Argenx Q1 Earnings: Less Than Perfect Report Gets Punished - Seeking Alpha
- 2 months ago - argenx SE (ARGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - argenx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire